Sanofi Consumer Healthcare India Ltd vs Zim Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 4629 as of 12 Jun 15:30 . The P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 54.9 on March 2026 . This represents a CAGR of 22.68% over 6 years The Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 320.31 crore on March 2026 . This represents a CAGR of 18.15% over 6 years The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Zim Laboratories Ltd for the Mar '26 is ₹ 111.44 crore as compare to the Dec '25 revenue of ₹ 110.36 crore. This represent the growth of 0.98% The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Zim Laboratories Ltd for the Mar '26 is ₹ 13.35 crore as compare to the Dec '25 ebitda of ₹ 14.51 crore. This represent the decline of -7.99% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Zim Laboratories Ltd changed from ₹ 0.9 crore to ₹ 3.74 crore over 8 quarters. This represents a CAGR of 103.85% The Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 71.85 % on December 2025 . This represents a CAGR of 128.03% over 3 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on December 2025 . This represents a CAGR of 0.0% over 9 years .

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Zim Laboratories Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 10,661 Cr while Market cap of Zim Laboratories Ltd is 604 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd?

As of June 14, 2026, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹4629.1. On the other hand, Zim Laboratories Ltd stock price is INR ₹112.95.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.